Ordering both Comirnaty concentrate vaccines by PCN Designated Sites

Tracy Rogers, Director, Medicines Use & Safety, Medicines Use and Safety TeamPublished Last updated See all updates

Information about ordering Comirnaty concentrate for Children 5-11 years and Comirnaty concentrate for adults and adolescents by PCN Sites


Where a pull model is in operation, the order should be placed on Foundry.

If you experience any issues associated with ordering or delivery of vaccine and consumables then see Dealing with delivery issues associated with the COVID-19 vaccines and consumables for the contact details of the National Vaccine Service Desk.

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations

Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional who needs further advice, get in touch with us. We answer questions about Medicines Optimisation issues, including those about the COVID-19 vaccination programme. Help us to help you: tell us where on our site you were.

Change history

  1. Modified to described a pull model.
  1. Changed throughout to include Children 5-11 years product
  1. Link to page on dealing with delivery issues restored.
  1. Link to page on dealing with delivery issues removed as page no longer available
  1. The current content is still accurate.
  1. Page updated with link to page on dealing with delivery issues
  1. SOP suspended and attachment removed from page
  1. Associated supplies -Updated to reflect current supplies
  2. Entire document - PCN Clinical Director changed to Lead GP
  3. Published